| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Albendazole-induced liver injury in children: a cause for concern?
|
Ezhilarasan, Devaraj
|
|
|
30 |
2 |
p.
|
artikel
|
| 2 |
Antimicrobial peptides: An alternative strategy to combat antimicrobial resistance
|
Gani, Zahid
|
|
|
30 |
2 |
p.
|
artikel
|
| 3 |
Applications and emerging challenges of single-cell RNA sequencing technology in tumor drug discovery
|
Zhang, Lu
|
|
|
30 |
2 |
p.
|
artikel
|
| 4 |
Artificial intelligence in peptide-based drug design
|
Zhai, Silong
|
|
|
30 |
2 |
p.
|
artikel
|
| 5 |
Benchmarking R&D success rates of leading pharmaceutical companies: an empirical analysis of FDA approvals (2006–2022)
|
Schuhmacher, Alexander
|
|
|
30 |
2 |
p.
|
artikel
|
| 6 |
Biomedical data analytics for better patient outcomes
|
Ghofrani, Alireza
|
|
|
30 |
2 |
p.
|
artikel
|
| 7 |
Carbohydrate kinase inhibition: a promising strategy in cancer treatment
|
Jain, Archit
|
|
|
30 |
2 |
p.
|
artikel
|
| 8 |
Competition of regulatory ecosystems in approving medicines: policy implications in the case of Europe
|
Franco, Pedro
|
|
|
30 |
2 |
p.
|
artikel
|
| 9 |
Computational approaches for the identification of novel metal-binding pharmacophores: advances and challenges
|
Xiong, Guoli
|
|
|
30 |
2 |
p.
|
artikel
|
| 10 |
Death ligand receptor (DLR) signaling: Its non-apoptotic functions in cancer and the consequences of DLR-directed therapies
|
Rashid, Khalid
|
|
|
30 |
2 |
p.
|
artikel
|
| 11 |
Diffused responsibilities in technology-driven health research: The case of artificial intelligence systems in decentralized clinical trials
|
Muller, Sam H.A.
|
|
|
30 |
2 |
p.
|
artikel
|
| 12 |
Is ChatGPT Ready for Public Use in Organ-Specific Drug Toxicity Research?
|
Connor, Skylar
|
|
|
30 |
2 |
p.
|
artikel
|
| 13 |
Modulating the phosphorylation status of target proteins through bifunctional molecules
|
He, Qindi
|
|
|
30 |
2 |
p.
|
artikel
|
| 14 |
Molecular biomarkers of glial activation and injury in epilepsy
|
Kalsariya, Reema A.
|
|
|
30 |
2 |
p.
|
artikel
|
| 15 |
Multi-layer platform coordination for open innovation in oligonucleotide therapeutics
|
Kawata, Yayoi
|
|
|
30 |
2 |
p.
|
artikel
|
| 16 |
Nanozyme-based synergistic therapeutic strategies against tumors
|
Zhang, Ye
|
|
|
30 |
2 |
p.
|
artikel
|
| 17 |
Philanthropic drug development: understanding its importance, mechanisms, and future prospects
|
Reichel, Marc
|
|
|
30 |
2 |
p.
|
artikel
|
| 18 |
Revolutionizing Cancer Care: The Promise of Nanoscale Metal-Organic Frameworks in Theranostics
|
Dongsar, Tenzin Tsering
|
|
|
30 |
2 |
p.
|
artikel
|
| 19 |
The epigenetic impact of fatty acids as DNA methylation modulators
|
Ediriweera, Meran Keshawa
|
|
|
30 |
2 |
p.
|
artikel
|
| 20 |
The impact of operational trial approaches on representativeness: Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice
|
de Jong, Amos J.
|
|
|
30 |
2 |
p.
|
artikel
|
| 21 |
The Value in Failure
|
Lawson, Alastair D.G.
|
|
|
30 |
2 |
p.
|
artikel
|
Tijdschrift beschrijving